Macquarie Upgrades Fisher & Paykel Healthcare to Outperform From Neutral; Price Target Is NZ$39.20
JPMorgan Upgrades Fisher & Paykel Healthcare to Neutral From Underweight; Price Target Is NZ$24.00
Morgan Stanley Adjusts Fisher & Paykel Healthcare's Price Target to AU$22.19 From AU$21.50, Keeps at Equalweight
No Data
No Data